The forecasted data indicates a consistent year-on-year decline in hospital discharges for Multiple Sclerosis cases in the UK, with figures decreasing by approximately 5% annually from 2024. The compound annual growth rate (CAGR) over the five-year forecast period is negative, reflecting a continued decrease in discharges per hundred thousand persons from 2023. In 2023, the figures stood at around 6.1 units, highlighting a notable decline through to 2028.
Future trends to watch for include:
- Advancements in treatment options and early diagnosis potentially reducing hospitalization rates.
- Healthcare policy changes that may impact hospital admission criteria or data reporting practices.
- Increased prevalence of outpatient management for Multiple Sclerosis, thereby reducing the need for hospital discharges.
